Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Lundman

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Cardiology|October 7, 2005
Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitroDaniel P Sieveking, Kam-Sang Woo, Kwok P Fung, et al.
Cardiovascular Diabetology|June 15, 2021
Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1cStelios Karayiannides, Catarina Djupsjö, Jeanette Kuhl, et al.
Atherosclerosis|October 25, 2012
High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosisJonas Persson, Lasse Folkersen, Johan Ekstrand, et al.
Open Heart|June 4, 2020
Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass graftingCatarina Djupsjo, Ulrik Sartipy, Torbjorn Ivert, et al.
Clinical Biochemistry|December 25, 2019
Corrigendum to "Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis" [Clin. Biochem. 64 (2019) 24-29]Michael K Palmer, Philip J Barter, Pia Lundman, et al.
Clinical Biochemistry|October 27, 2018
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysisMichael K Palmer, Philip J Barter, Pia Lundman, et al.
Circulation|August 26, 2009
Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Karolina Szummer, Pia Lundman, Stefan H Jacobson, et al.
Kidney International|January 14, 2011
Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarctionKarolina Szummer, Pia Lundman, Stefan H Jacobson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 7, 2020
Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17Ali Allahyari, Tomas Jernberg, Dominik Lautsch, et al.
European Journal of Preventive Cardiology|June 6, 2024
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individualsAli Yari, Peter Ueda, Pia Lundman, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|October 7, 2005
Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitroDaniel P Sieveking, Kam-Sang Woo, Kwok P Fung, et al.
Cardiovascular Diabetology|June 15, 2021
Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1cStelios Karayiannides, Catarina Djupsjö, Jeanette Kuhl, et al.
Atherosclerosis|October 25, 2012
High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosisJonas Persson, Lasse Folkersen, Johan Ekstrand, et al.
Open Heart|June 4, 2020
Preoperative disturbances of glucose metabolism and mortality after coronary artery bypass graftingCatarina Djupsjo, Ulrik Sartipy, Torbjorn Ivert, et al.
Clinical Biochemistry|December 25, 2019
Corrigendum to "Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis" [Clin. Biochem. 64 (2019) 24-29]Michael K Palmer, Philip J Barter, Pia Lundman, et al.
Clinical Biochemistry|October 27, 2018
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysisMichael K Palmer, Philip J Barter, Pia Lundman, et al.
Circulation|August 26, 2009
Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Karolina Szummer, Pia Lundman, Stefan H Jacobson, et al.
Kidney International|January 14, 2011
Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarctionKarolina Szummer, Pia Lundman, Stefan H Jacobson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|March 7, 2020
Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17Ali Allahyari, Tomas Jernberg, Dominik Lautsch, et al.
European Journal of Preventive Cardiology|June 6, 2024
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individualsAli Yari, Peter Ueda, Pia Lundman, et al.
Pageof 7